 AMSTERDAM, July 22, 2021 PRNewswire -- LUMICKS, a leading next generation life science tools company renowned for its innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, has installed its ground-breaking z-Movi Cell Avidity Analyzer at INmune Bio NASDAQ: INMB. INmune Bio is a clinical stage biotechnology company developing new therapies that modulate the innate immune system to treat cancer and neurodegenerative diseases, such as Alzheimers. 